
Hormones
CJC-1295 (no DAC)
"CJC-1295 (no DAC)", also sold as modified GRF (1-29), refers to a tetrasubstituted analog of growth hormone-releasing hormone (1-29) without the albumin-binding drug affinity complex that defines CJC-1295 proper.
- Container
- Glass vial, crimp seal, flip-top cap
- Storage
- -20 °C, desiccated
- Paperwork
- Lot certificate (HPLC + mass spec) shown before you pay
Lot certificates
You’ll see American Peptides on the lab’s copy. They’re our supplier.
- 10 mg, lot CJC10-0803: 99.76% purity (RP-HPLC), 10.38 mg measured, identity confirmed by mass spec. Issued 2026-08-28 by Bioviridian Inc.. Verify certificate COA7601
Our vials are filled from lots made by our supplier, American Peptides, and tested by Bioviridian Inc.The laboratory’s original certificate lists American Peptides as the vendor. Look up the code at bioviridians.com to check it.
What researchers study it for
- Structural analog of GHRH(1-29)
- Doping-control detection in seized material
How it is thought to work
As a GHRH(1-29) analog, it is expected to act on the GHRH receptor of pituitary somatotrophs, but this is inferred from related compounds rather than measured directly. The published CJC-1295 human data (Teichman 2006) concern the DAC version, whose albumin binding extends half-life; those results do not transfer to this form.
Where the research stands
No published human studies. A 2026 peer-reviewed review found no peer-reviewed human studies of CJC-1295 without DAC, placing it in its lowest evidence tier.
Sources
- Jetté L, Léger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, Paradis V, van Wyk P, Pham K, Bridon DP (2005). Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog.. Endocrinology.
- Dominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, Ruchała M (2026). The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.. Front Endocrinol (Lausanne).
- Gajda PM, Holm NB, Hoej LJ, Rasmussen BS, Dalsgaard PW, Reitzel LA, Linnet K (2019). Glycine-modified growth hormone secretagogues identified in seized doping material.. Drug Test Anal.
- Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.. J Clin Endocrinol Metab.
Read more
For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.
